Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-02

FDA Approved: LETROZOLE — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

The FDA approved a supplemental application granting approval for Accord Healthcare, Inc.'s generic letrozole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)